Mitchell C. Posner to Treatment Outcome
This is a "connection" page, showing publications Mitchell C. Posner has written about Treatment Outcome.
Connection Strength
0.661
-
An Update on Randomized Clinical Trials in Gastric Cancer. Surg Oncol Clin N Am. 2017 10; 26(4):621-645.
Score: 0.061
-
Transhiatal Esophagectomy for Esophageal Cancer. J Laparoendosc Adv Surg Tech A. 2016 Oct; 26(10):752-756.
Score: 0.056
-
Modern treatment of gastric gastrointestinal stromal tumors. World J Gastroenterol. 2012 Dec 14; 18(46):6720-8.
Score: 0.043
-
A phase II trial of neoadjuvant chemoradiation and local excision for T2N0 rectal cancer: preliminary results of the ACOSOG Z6041 trial. Ann Surg Oncol. 2012 Feb; 19(2):384-91.
Score: 0.039
-
Transhiatal versus transthoracic esophagectomy for esophageal cancer. World J Gastroenterol. 2010 Aug 14; 16(30):3804-10.
Score: 0.037
-
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. Ann Surg Oncol. 2008 Jan; 15(1):158-64.
Score: 0.031
-
D3 or not D3... that is not the question. Lancet Oncol. 2006 Apr; 7(4):279-80.
Score: 0.027
-
Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin Transplant. 2004 Oct; 18(5):502-12.
Score: 0.025
-
Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): safety and efficacy. Am J Transplant. 2003 Mar; 3(3):312-7.
Score: 0.022
-
Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma. Ann Surg Oncol. 2002 Jun; 9(5):500-4.
Score: 0.021
-
Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma. Arch Surg. 2001 Jul; 136(7):737-42; discussion 743.
Score: 0.020
-
Surgical management of benign tumors of the liver. Int J Gastrointest Cancer. 2001; 30(3):141-6.
Score: 0.019
-
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
Score: 0.019
-
Hepatic resection: effective treatment for primary and secondary tumors. Surgery. 2000 Oct; 128(4):686-93.
Score: 0.019
-
Total Pancreatectomy with Islet Autotransplantation for the Ampullary Cancer. A Case Report. J Gastrointest Cancer. 2019 09; 50(3):543-547.
Score: 0.017
-
Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden. Ann Oncol. 2019 05 01; 30(5):744-756.
Score: 0.017
-
p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma. Cancer. 1998 Jul 01; 83(1):7-18.
Score: 0.016
-
Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. J Surg Oncol. 2018 Mar; 117(3):354-362.
Score: 0.015
-
Extremes of body mass index and postoperative complications after esophagectomy. Dis Esophagus. 2017 May 01; 30(5):1-6.
Score: 0.015
-
Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma. Cancer J Sci Am. 1995 Nov-Dec; 1(4):274-80.
Score: 0.013
-
Effect of Laparoscopic-Assisted Resection vs Open Resection of Stage II or III Rectal Cancer on Pathologic Outcomes: The ACOSOG Z6051 Randomized Clinical Trial. JAMA. 2015 Oct 06; 314(13):1346-55.
Score: 0.013
-
Preservation of beta cell function after pancreatic islet autotransplantation: University of Chicago experience. Am Surg. 2015 Apr; 81(4):421-7.
Score: 0.013
-
Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. J Natl Cancer Inst. 2014 Jul; 106(7).
Score: 0.012
-
Complete endoscopic mucosal resection is effective and durable treatment for Barrett's-associated neoplasia. Clin Gastroenterol Hepatol. 2014 Dec; 12(12):2002-10.e1-2.
Score: 0.012
-
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointest Endosc. 2012 Feb; 75(2):332-8.
Score: 0.010
-
Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting. J Clin Oncol. 2011 Mar 01; 29(7):934-43.
Score: 0.010
-
Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial. Ann Surg Oncol. 2011 Feb; 18(2):337-44.
Score: 0.009
-
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol. 2011 Dec; 28 Suppl 1:S152-61.
Score: 0.009
-
Distal extrahepatic cholangiocarcinoma presenting as cholangitis. Dig Dis Sci. 2010 Jul; 55(7):1852-5.
Score: 0.009
-
Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Am J Gastroenterol. 2009 Nov; 104(11):2684-92.
Score: 0.009
-
Successful palliation of hypercalcemia secondary to metastatic parathyroid cancer: an unusual indication for hepatic resection. J Hepatobiliary Pancreat Surg. 2007; 14(4):410-3.
Score: 0.007
-
Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study. Ann Oncol. 1998 Sep; 9(9):1035-7.
Score: 0.004
-
Efficacy of cisplatin, 5-fluorouracil, and paclitaxel regimen for carcinoma of the esophagus. Semin Oncol. 1997 Dec; 24(6 Suppl 19):S19-89-S19-92.
Score: 0.004
-
Phase II study of topotecan in metastatic non-small-cell lung cancer. J Clin Oncol. 1994 Feb; 12(2):347-52.
Score: 0.003
-
Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg. 1993 May; 128(5):559-64.
Score: 0.003
-
New method of limb deformities correction in children. Bull N Y Acad Med. 1992 Nov; 68(4):447-69.
Score: 0.003